| Literature DB >> 26166574 |
Ze-Yi Zheng1, Lin Tian2, Wen Bu1, Cheng Fan3, Xia Gao1, Hai Wang1, Yi-Hua Liao4, Yi Li5, Michael T Lewis5, Dean Edwards6, Thomas P Zwaka7, Susan G Hilsenbeck1, Daniel Medina6, Charles M Perou3, Chad J Creighton8, Xiang H-F Zhang5, Eric C Chang9.
Abstract
Basal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have found that wild-type N-RAS is overexpressed in BLBCs but not in other breast cancer subtypes. Repressing N-RAS inhibits transformation and tumor growth, whereas overexpression enhances these processes even in preinvasive BLBC cells. We identified N-Ras-responsive genes, most of which encode chemokines; e.g., IL8. Expression levels of these chemokines and N-RAS in tumors correlate with outcome. N-Ras, but not K-Ras, induces IL-8 by binding and activating the cytoplasmic pool of JAK2; IL-8 then acts on both the cancer cells and stromal fibroblasts. Thus, BLBC progression is promoted by increasing activities of wild-type N-Ras, which mediates autocrine/paracrine signaling that can influence both cancer and stroma cells.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26166574 PMCID: PMC4512851 DOI: 10.1016/j.celrep.2015.06.044
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423